Dirigo
I direct
To ban the sale of products with a high concentration of sodium nitrite to individuals, and for other purposes.
The bill reduces public access to a high-risk chemical to lower poisoning risks—particularly for vulnerable consumers—while limiting impacts on foods and medical products, but it imposes short-term compliance costs on businesses and implementation strain on regulators.
Right to IVF Act of 2026
The bill greatly expands and protects nationwide access to ART/IUI and fertility preservation—especially for federal beneficiaries, military members, and marginalized groups—but does so at the cost of higher public and private spending, greater federal-state legal conflicts and litigation, implementation burdens, and some unresolved drafting and conscience-accommodation tensions.
Water Emergency and Technical Assistance Act
The bill provides a targeted, multi-year federal funding stream to strengthen drinking-water emergency response and resilience—reducing public health risks and local rate pressure—but increases authorized federal spending and relies on future appropriations and agency judgments that could limit or unevenly distribute actual support.
To amend title XIX of the Social Security Act to establish a definition of essential health system in statute and for other related purposes.
The bill creates a transparent, five‑year designation system to target and stabilize support for safety‑net hospitals and preserve local access to care, but it may exclude some community hospitals that don’t fit Medicare‑based metrics and adds administrative burdens that could leave vulnerable patients worse off.
To direct the Secretary of Defense to establish a pilot program to facilitate the development of certain traumatic brain injury diagnostics for members of the Armed Forces.
The bill funds a time-limited DoD pilot to speed validation and U.S. manufacturing of rapid TBI diagnostics—likely improving military TBI care and supporting domestic innovators—but its limited scope, duration, and grant preferences may constrain clinical impact, competition, and long-term adoption.
College Athletics Reform Act
The bill expands college athletes' ability to monetize NIL and strengthens agent oversight and public accountability, but shifts costs and enforcement away from campuses and states—raising litigation, compliance, competitive-balance, and privacy risks that could disproportionately burden institutions and smaller programs.
MY DATA Act of 2025
The bill expands individuals' ability to use de-identified or cloaked data and clarifies FTC enforcement and definitions to enable privacy-preserving uses, but it increases compliance and enforcement exposure for businesses and raises re-identification and legal-uncertainty risks for consumers and service providers.
Protect Patients from Healthcare Abuse Act
The bill strengthens patient rights and safety in Medicare-covered sensitive exams by requiring informed-consent notices, the option for trained chaperones, and staff training, but imposes compliance costs on providers, added reporting obligations, and may create complexity for some vulnerable patients under varying state consent rules.
Pipeline Accountability Act of 2025
The bill strengthens pipeline safety, transparency, and climate-oriented funding—benefiting nearby communities and emergency preparedness—but does so at the cost of higher compliance, administrative, litigation, and taxpayer expenses and some regulatory uncertainty.
HEADACHE Act
The bill concentrates federal attention, coordination, research, and data efforts to improve diagnosis, care, and equity for people with chronic headache disorders, but it requires new federal spending, administrative work, and data sharing that raise privacy risks and create uncertainty for beneficiaries because the program sunsets after five years.